# Gilford

- Location (FDA's records): Oberlin, OH
- FDA decisions: 10 (1981–1985): 10 510(k) clearances
- Product codes: JJE (3), CZP (1), DEW (1), CZW (1), DBI (1), DFT (1), LFX (1), DAK (1)
- Predicates its devices cite: 0 (0 its own); citations of its devices by later devices: 3 (0 its own)
- Recalls linked to its devices: 0 (0 Class I)
- Data: FDA decisions to Oct 25, 2026; recalls to Oct 12, 2026

## Firms that cite its devices most
- Kamiya Biomedical Co.: 3 (https://510kreport.com/company/kamiya-biomedical)

## Its most-cited devices
- K851202: Gilford Tri-Level Assayed Immunology Control (1985), cited by 3

## Recent decisions
- K853467: Gilford Immunoglobulin a Reagent (Sep 16, 1985)
- K853465: Gilford Immunoglobulin G Reagent (Sep 16, 1985)
- K853466: Gilford C3 Complement Reagent (Sep 16, 1985)
- K853468: Gilford C4 Complement Reagent (Sep 16, 1985)
- K853469: Gilford Immunoglobulin M Reagent (Sep 16, 1985)
- K851202: Gilford Tri-Level Assayed Immunology Control (Apr 29, 1985)
- K842500: Data MGMT. System (Aug 16, 1984)
- K840120: Advantage (Mar 23, 1984)

Source page: https://510kreport.com/company/gilford